[Pharmacoeconomics of ulcers: a view from Saint-Petersburg].
Only in Saint Petersburg the application of omeprazole, hiconcil and fromilid in the treatment of adult patients with duodenal ulcer could save up to 26 million rubles per year due to the decrease in the number of recurrences. Yet these funds are still wasted with the persistence worthy of better application, since most general practitioners do not realize either economic or even clinical value of eradication. The above-mentioned calculations provide a ground for reflections on the improvement of methods of advanced training for specialists with the use of pharmacoepidemiological and pharmacoeconomic grounds for the selection of optimum remedies for the treatment of duodenal ulcer. A thorough clinical and economic evaluation of our actions, methods and preparations for treatment will make it possible to enhance the efficiency and quality of treatment, to avoid not only considerable undesirable drug reactions but also unjustified social costs in the way it is done in many countries.
Karpov
O I
OI
Laboratory of Pharmacoepidemiology and Pharmacoeconomy, Institute of Pharmacology, I.P. Pavlov Saint Petersburg State Medical University.
D017850:Economics, Pharmaceutical; D012426:Russia; D014456:Ulcer / Q000188:drug therapy* / Q000191:economics*